Advisor Shares Investments LLC Cardiol Therapeutics Inc. Transaction History

Advisor Shares Investments LLC

  • $536 Million
  • Q2 2025

A detailed history of Advisor Shares Investments LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Shares Investments LLC holds 857,388 shares of CRDL stock, worth $968,848. This represents 0.22% of its overall portfolio holdings.

Number of Shares
857,388
Previous 982,488 12.73%
Holding current value
$968,848
Previous $953,000 22.35%
% of portfolio
0.22%
Previous 0.19%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025
SELL
$0.81 - $1.47 $101,331 - $183,897
-125,100 Reduced 12.73%
857,388 $1.17 Million
Q1 2025

May 13, 2025
BUY
$0.96 - $1.46 $96,000 - $146,000
100,000 Added 11.33%
982,488 $953,000
Q4 2024

Feb 14, 2025
SELL
$1.25 - $2.07 $360,476 - $596,948
-288,381 Reduced 24.63%
882,488 $1.14 Million
Q3 2024

Nov 14, 2024
SELL
$1.83 - $2.48 $541,868 - $734,335
-296,103 Reduced 20.18%
1,170,869 $2.32 Million
Q2 2024

Aug 07, 2024
BUY
$1.67 - $2.97 $275,539 - $490,032
164,994 Added 12.67%
1,466,972 $2.96 Million
Q1 2024

May 14, 2024
BUY
$0.88 - $2.06 $98,560 - $230,720
112,000 Added 9.41%
1,301,978 $2.36 Million
Q4 2023

Feb 13, 2024
SELL
$0.67 - $1.0 $10,592 - $15,810
-15,810 Reduced 1.31%
1,189,978 $999,000
Q3 2023

Nov 06, 2023
SELL
$0.76 - $1.19 $10,602 - $16,600
-13,950 Reduced 1.14%
1,205,788 $1.09 Million
Q2 2023

Aug 09, 2023
BUY
$0.45 - $0.97 $18,000 - $38,800
40,000 Added 3.39%
1,219,738 $1.09 Million
Q1 2023

May 09, 2023
BUY
$0.47 - $0.81 $37,105 - $63,947
78,948 Added 7.17%
1,179,738 $578,000
Q4 2022

Feb 14, 2023
BUY
$0.48 - $1.0 $528,379 - $1.1 Million
1,100,790 New
1,100,790 $561,000
Q1 2021

May 11, 2021
SELL
$2.08 - $4.08 $725,439 - $1.42 Million
-348,769 Closed
0 $0
Q4 2020

Jan 25, 2021
BUY
$1.84 - $2.64 $113,459 - $162,790
61,663 Added 21.48%
348,769 $970,000
Q3 2020

Nov 12, 2020
BUY
$1.51 - $2.58 $65,839 - $112,493
43,602 Added 17.91%
287,106 $876,000
Q2 2020

Jul 14, 2020
BUY
$1.68 - $2.34 $55,497 - $77,299
33,034 Added 15.7%
243,504 $577,000
Q1 2020

May 13, 2020
BUY
$1.4 - $3.63 $24,906 - $64,577
17,790 Added 9.23%
210,470 $600,000
Q4 2019

Jan 22, 2020
BUY
$1.9 - $3.54 $366,092 - $682,087
192,680 New
192,680 $681,000

Others Institutions Holding CRDL

# of Institutions
43
Shares Held
6.74M
Call Options Held
37.6K
Put Options Held
0
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $70M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Advisor Shares Investments LLC Portfolio

Follow Advisor Shares Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email